Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England

Author
M. Pufulete
J. Harris
K. Pouwels
B. Reeves
D. Lasserson
Y. Loke
A. Mumford
K. Mahadevan
T. Johnson
Keywords
*Acute Coronary Syndrome/diagnosis/therapy
Adolescent
Aspirin/adverse effects
Clopidogrel/adverse effects
Cohort Studies
Dinucleoside Phosphates
Hemorrhage/chemically induced/epidemiology
Humans
*Percutaneous Coronary Intervention/adverse effects
Platelet Aggregation Inhibitors/adverse effects
Prasugrel Hydrochloride/adverse effects
Retrospective Studies
*ST Elevation Myocardial Infarction/diagnosis/therapy
Ticagrelor/adverse effects
acute coronary syndrome
Electronic Health Records
epidemiology
percutaneous coronary intervention
pharmacology, clinical
Year of Publication
2022
Journal
Open Heart
Volume
9
ISBN Number
2053-3624 (Print)2053-3624
Accession Number
35961692
DOI
10.1136/openhrt-2022-001999